Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

19.01

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

-1.93

EPS Last/This Y

1.09

EPS This/Next Y

1.03

Price

29.48

Target Price

35.89

Analyst Recom

2.92

Performance Q

23.37

Relative Volume

1.1

Beta

1.18

Ticker: MRNA




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13MRNA24.950.810.271051051
2025-11-14MRNA24.770.800.161064265
2025-11-17MRNA24.720.820.531018236
2025-11-18MRNA24.890.811.421026160
2025-11-19MRNA24.170.820.361027951
2025-11-20MRNA22.340.790.601060568
2025-11-21MRNA23.730.760.361097256
2025-11-24MRNA24.140.750.55928150
2025-11-25MRNA24.750.750.71936334
2025-11-26MRNA250.750.23946581
2025-12-01MRNA24.190.771.85927413
2025-12-02MRNA24.060.790.88955212
2025-12-03MRNA25.170.790.99970083
2025-12-04MRNA25.420.791.17977812
2025-12-05MRNA27.70.790.17988149
2025-12-08MRNA27.970.770.45967101
2025-12-09MRNA28.250.730.57997816
2025-12-10MRNA29.020.730.211025708
2025-12-11MRNA29.620.740.381027855
2025-12-12MRNA29.470.760.651065704
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13MRNA24.953.7212.0-8.04
2025-11-14MRNA24.763.7-82.4-8.04
2025-11-17MRNA24.763.7-122.9-8.04
2025-11-18MRNA24.913.7-157.5-8.02
2025-11-19MRNA24.183.734.1-8.02
2025-11-20MRNA22.363.7284.8-8.02
2025-11-21MRNA23.733.7-477.3-7.99
2025-11-24MRNA24.143.7-222.9-7.99
2025-11-25MRNA24.755.3-88.6-8.08
2025-11-26MRNA25.005.3-11.3-8.08
2025-12-01MRNA24.185.3382.0-8.09
2025-12-02MRNA24.065.361.1-8.09
2025-12-03MRNA25.185.3-201.0-8.09
2025-12-04MRNA25.475.3-17.9-8.09
2025-12-05MRNA27.705.3-393.1-8.09
2025-12-08MRNA27.975.3- -8.19
2025-12-09MRNA28.245.3-5.8-8.19
2025-12-10MRNA29.035.3-92.2-8.19
2025-12-11MRNA29.625.3-54.5-8.19
2025-12-12MRNA29.485.363.1-8.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13MRNA-0.00-0.2218.21
2025-11-14MRNA-0.00-0.2218.21
2025-11-17MRNA-0.00-0.7918.18
2025-11-18MRNA-0.00-0.7918.18
2025-11-19MRNA-0.00-0.7918.18
2025-11-20MRNA-0.00-0.7918.18
2025-11-21MRNA-0.00-0.7918.37
2025-11-24MRNA-0.00-3.6418.37
2025-11-25MRNA-0.00-3.6418.37
2025-11-26MRNA-0.00-3.6418.57
2025-12-01MRNA-0.00-3.6018.57
2025-12-02MRNA-0.00-3.6018.57
2025-12-03MRNA-0.00-3.6018.57
2025-12-04MRNA-0.00-3.6018.57
2025-12-05MRNA-0.00-3.6018.57
2025-12-08MRNA-0.00-3.6617.97
2025-12-09MRNA-0.00-3.6617.97
2025-12-10MRNA-0.00-3.6619.01
2025-12-11MRNA-0.00-3.6619.01
2025-12-12MRNA-0.00-3.6619.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="MRNA" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.51

Avg. EPS Est. Current Quarter

-2.73

Avg. EPS Est. Next Quarter

-2.44

Insider Transactions

Institutional Transactions

-3.66

Beta

1.18

Average Sales Estimate Current Quarter

626

Average Sales Estimate Next Quarter

187

Fair Value

Quality Score

38

Growth Score

33

Sentiment Score

51

Actual DrawDown %

94.1

Max Drawdown 5-Year %

-95.4

Target Price

35.89

P/E

Forward P/E

PEG

P/S

5.16

P/B

1.23

P/Free Cash Flow

EPS

-8.06

Average EPS Est. Cur. Y​

-8.19

EPS Next Y. (Est.)

-7.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-139.61

Relative Volume

1.1

Return on Equity vs Sector %

-60.3

Return on Equity vs Industry %

-45.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

1.58

EBIT Estimation

63.1
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”MRNA” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”MRNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Moderna, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 5800
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading